Clinical Characteristics of Fungal Peritonitis from Peritoneal Dialysis Patients.
- Author:
Kook Hwan OH
1
;
Cu Rie AHN
;
Yoon Kyu OH
;
Hyun Lee KIM
;
Woo Kyung CHUNG
;
Yon Su KIM
;
Jin Suk HAN
;
Suhng Gwon KIM
;
Jung Sang LEE
Author Information
1. Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea. curie@plaza.snu.ac.kr
- Publication Type:Original Article
- Keywords:
Fungus;
Peritonitis;
Peritoneal Dialysis;
PD;
Candida
- MeSH:
Amphotericin B;
Aspergillus;
Candida;
Catheters;
Cryptococcus;
Diagnosis;
Female;
Fluconazole;
Flucytosine;
Fungi;
Humans;
Male;
Mortality;
Penicillium;
Peritoneal Dialysis*;
Peritonitis*;
Retrospective Studies;
Seoul;
Trichosporon
- From:Korean Journal of Nephrology
2002;21(2):303-311
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Fungal peritonitis is a fatal disease with a high mortality and morbidity to the peritoneal dialysis(PD) patients. This study was implemented to provide a guideline for the prevention and treatment of fungal peritonitis in PD patients by analyzing the clinical and microbiologic features of fungal peritonitis cases. METHODS: We analyzed retrospectively into the 15 cases(14 patients) of fungal peritonitis among 376 end stage renal disease(ESRD) patients who newly started PD in the Seoul National University Hospital from Jan. 1991 to Dec. 1999. RESULTS: The patients' age was 53.6+/-11.6 years (mean+/-standard deviation) and their male to female ratio was 12:3. They have been on PD for 29.2+/-27.7 months before the fungal peritonitis developed. Candida species was the most common etiologic agent, accounting for 10(62.5%) out of the 16 fungal organisms isolated from our patients. Among others were two Aspergillus, one Cryptococcus, one Penicillium, one Torulopsis, and one Trichosporon beigelii cases. Bacterial agents were isolated simultaneously in five fungal peritonitis cases. Peritoneal catheters were all removed no later than 72 hours after the diagnosis was made. Patients were given a single or combined therapy with amphotericin B, fluconazole, or flucytosine on the physician's choice. The outcomes of fungal peritonitis were as follows; 20% continued PD, 60% converted to HD and 20% died of fungal peritonitis. We made a comparative analysis between the fungal and bacterial peritonitis cases which developed in the same 5-year period, which showed significantly higher catheter removal and technique failure rates in the fungal cases. CONCLUSION: Fungal peritonitis is a rare but a fatal disease with a high mortality and a technique failure rate. Candida species was the most prevalent microorganism in our study.
